A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AA / abiraterone

[Related PubMed/MEDLINE]
Total Number of Papers: 10
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AA  (>> Co-occurring Abbreviation)
Long Form:   abiraterone
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Abiraterone Acetate and Enzalutamide: Similar Efficacy in Treating Post Docetaxel Metastatic Castration-resistant Prostate Cancer: Single Center Experience. ENZ, mCRPC, OS, PFS, PSA
2019 Cost-effectiveness of abiraterone versus docetaxel in the treatment of metastatic hormone naive prostate cancer. ADT, DCT, PF-QALYs
2018 Abiraterone Followed by Enzalutamide Versus Enzalutamide Followed by Abiraterone in Chemotherapy-naive Patients With Metastatic Castration-resistant Prostate Cancer. AA-ENZA, ENZA, PFS, PSA
2018 Systemic immune-inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patients. DP, mCRPC, OS, rPFS, SII
2017 Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration-resistant prostate cancer patients treated with abiraterone. mCRPC, OS, PNI, rPFS
2017 Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone. mCRPC, OS, rPFS
2016 Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme. CRPC, mCRPC, OS, PFS
2014 Abiraterone acetate in metastatic castration-resistant prostate cancer: a retrospective review of the Princess Margaret experience of (I) low dose abiraterone and (II) prior ketoconazole. bPFS, KT, mCRPC, OS, PSA-RR
2014 Initial experience with abiraterone acetate in patients with castration-resistant prostate cancer. MCRPC
10  2013 Expert opinion on chemotherapy use in castration-resistant prostate cancer progressing after docetaxel. CBZ, CRPC, ENZ